Targeting DCAF1 as a novel treatment strategy for therapy resistant multiple myeloma

  • Kats, Lev (Primary Chief Investigator (PCI))
  • Shortt, Jake (Chief Investigator (CI))
  • Thompson, Philip (Chief Investigator (CI))
  • Ott, Christopher J. (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/10/2130/09/24

Funding

  • Leukemia & Lymphoma Society: A$896,406.82